Common antiplatelet medications include aspirin, which inhibits the enzyme cyclooxygenase-1 (COX-1), and clopidogrel, which blocks the P2Y12 receptor on platelets. By preventing platelets from ...

Dual antiplatelet therapy with aspirin and clopidogrel is effective in limiting adverse coronary thromboischemic events in most patients undergoing coronary stenting. However, platelet reactivity ...

Aspirin improves clinical outcome in all cardiovascular ... in the production of this manuscript. The combined use of antiplatelet drugs acting through different mechanisms is important in ...

Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its superior antiplatelet potency compared with ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...

Michael Mosley talks to two experts with very different opinions on whether healthy people, who haven’t had a heart attack, should be taking a daily 75mg dose of aspirin. Professor Peter Elwood ...

Lucy Notarantonio is Newsweek's Senior Lifestyle and Trends Reporter, based in Birmingham, UK. Her focus is trending stories and human interest features ranging from health, pets and travel.

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

In our study, clopidogrel beat aspirin as a lifelong maintenance monotherapy after standard-duration dual antiplatelet therapy. Based on these results, I hope that guidelines will address ...

Aspire Biopharma (ASBP) announced initiation of its Phase 1 single- center clinical study of its lead therapeutic candidate, an oral ...